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Abstract
Background: The purpose of this study was to compare the surgical outcomes of robotic thyroidectomy (RT) using
bilateral axillo-breast approach (BABA) with conventional open thyroidectomy (OT) in papillary thyroid carcinoma
patients.
Methods: Between January 2009 and December 2013, 815 patients who had received thyroidectomy for papillary
thyroid carcinoma were enrolled. Of these, 126 patients received RT and 689 patients underwent OT. Age, gender,
body mass index, extent of surgery, tumor size, multiplicity, bilaterality, extrathyroidal extension, and tumor stage
were used for the propensity score matching analysis. One hundred and nine patients were selected in each group,
and surgical outcomes were compared between the two groups.
Results: The RT group showed a significantly longer operating time (290.6 ± 74.4 vs. 107.9 ± 30.8 min, P < 0.001).
However, the mean hospital stay after surgery (3.6 ± 0.8 vs. 3.4 ± 1.2 days, P = 0.293), postoperative complication
rates (major and minor, P = 0.754 and P = 0.852), and pain score (postoperative day, P = 0.669; postoperative day 1,
P = 0.952) were comparable between the two groups. There was no difference in the number of metastatic lymph
nodes, but the mean number of retrieved lymph nodes in the RT group was lesser than that in the OT group
(3.5 ± 3.5 vs. 5.3 ± 5.2, P = 0.002).
Conclusions: Robotic thyroidectomy via the BABA may be a safe and acceptable surgical technique. But, further
development that resolves the limitation of central node dissection is needed.
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Background
Since the time minimally invasive endoscopic thyroid
surgery has been introduced [1], various methods have
been developed to improve accessibility and cosmetic
satisfaction. Thereafter, minimally invasive surgery was
extended to the field of papillary thyroid carcinoma
(PTC) and many studies have reported favorable surgical
outcomes including outstanding cosmetic results [2–4].
But, endoscopic thyroidectomy has several limitations
such as restricted motion of surgical instruments and
two-dimensional camera view. These limitations were
reduced by using the da Vinci S robotic system (Intuitive
Surgical, Sunnyvale, CA) that offered several advantages
to the surgeon with a highly magnified three-dimensional
view, fine motor scaling, tremor-free, and endo-wrist
function [5, 6]. A number of studies showing promising
surgical outcomes of robotic thyroidectomy (RT) have
been published [7–26]. But, there has been no random-
ized study for RT and any other robotic surgery, and it
may be difficult to perform such a study in the near fu-
ture because of the fundamental limitation about the
cost issues. In particular, the issue concerning the onco-
logical safety of RT in PTC patients is debatable and
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there is no worldwide consensus on the definite indica-
tion for RT as yet. Therefore, we analyzed the results of
RT in our hospital for the last 5 years and compared
the surgical and oncological safety of RT with conven-
tional open thyroidectomy (OT) for analyzing the feasi-
bility of RT in PTC patients.
Methods
This retrospective cohort study was carried out between
January 2009 and December 2013 in the Department of
Surgery, Kyung Hee University Medical Center, Seoul,
South Korea. We included 815 PTC patients who under-
went thyroidectomy with or without central node dissec-
tion (CND). Of these, 689 patients received conventional
OT and 126 patients underwent RT using the bilateral
axillary breast approach (BABA) method (Fig. 1).
The decision regarding the operation methods, whether
robotic or conventional open thyroidectomy, was made
based on the patients’ preferences. Randomization of op-
erative methods was not possible because the cost of ro-
botic surgery is not reimbursed by national health
insurance; hence, the hospital cost for RT is two to three
times higher.
We conducted a propensity score matching analysis to
reduce treatment selection bias and potential confound-
ing effects [27]. We selected the following 10 factors that
could affect the surgical outcomes: age, sex, body mass
index (BMI), extent of surgery, extent of lymph node
dissection, tumor size, multiplicity, bilaterality, extrathyr-
oidal extension, and cancer stage [28]. One hundred and
nine patients were selected in each group, and surgical
outcomes were compared between the two groups.
RT was not recommended in cases with tumors >4 cm
or clinically evident lateral lymph node metastasis or
tumors located on the dorsal aspect of the thyroid with
suspicion of invasion into adjacent organs such as the
esophagus, trachea, or recurrent laryngeal nerve.
Unilateral or bilateral CND was conducted for prophylac-
tic or therapeutic purposes. Bilateral CND was performed
for bilateral tumors or in patients with contralateral suspi-
cious lymph node enlargement on preoperative evaluation
or intraoperative gross morphology. Lobectomy without
CND was performed only when there was a single tumor
<5 mm without extrathyroidal extension.
All patients were diagnosed with PTC or suspicious
for PTC by fine needle aspiration cytology. We per-
formed ultrasonography (US), computed tomography
(CT), and thyroid function tests in all patients.
Surgical outcomes
Details of surgery such as operation time, status of
parathyroid glands, and postoperative complications
were compared between the two groups. Transient
hypocalcemia was defined as the patients who received
calcium replacement to treat hypocalcemic symptoms
and who had a serum parathyroid hormone (PTH) level
<13 pg/mL regardless of their serum calcium levels. We
measured the PTH level at postoperative day (POD) 2.
The patients who had hoarseness with vocal cord palsy
confirmed by laryngoscopy were defined as having tran-
sient hoarseness. Permanent hypocalcemia was defined
as PTH level <13 pg/mL and the need for calcium or
vitamin D supplements for more than 6 months after
thyroidectomy. Permanent recurrent laryngeal nerve
palsy was diagnosed when they lasted over 6 months.
A drain was placed in the thyroid bed, and it was
removed when the amount of drainage was less than
40 mL in a day. Postoperative pain was evaluated using
an 11-point visual analog scale (VAS). Pain score was
checked at 1 h after surgery and once in a day until dis-
charge. Hospital cost was determined based on the in-
patient charges. The evaluation of an abnormal sequelae
or complication was routinely carried out at 2 weeks
after the operation and continued until 1 year after the
operation in an outpatient setting. Radioactive iodine
(RAI) ablation therapy was performed on the basis of
cancer stage and risk factors, according to the American
Thyroid Association (ATA) guidelines [29]. TSH-stimulated
thyroglobulin (Tg) levels in patients who received radioio-
dine therapy were analyzed to compare surgical complete-
ness between the two groups. TSH-stimulated Tg levels
were checked after withdrawal of levothyroxine or in-
jection of recombinant human thyrotropin, while TSH
levels were >30 μIU/mL. The stimulated Tg and TSH
Fig. 1 Patient selection
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levels were measured on the day of RAI ablation ther-
apy before RAI administration. The RAI dose ranged
from 30 mCi 131-I to 150 mCi 131-I. Patients received RAI
ablation therapy after 8–12 weeks after thyroidectomy.
Surgical procedures
All surgeries were performed by a single surgeon. We
used the BABA technique that was introduced by Lee
et al. [5] for RT. For the detailed procedure, please refer
to the bibliography [5]. The only difference was that we
injected normal saline instead of diluted epinephrine
(1:200,000) for flap elevation.
Statistical analysis
We used the Kolmogorov-Smirnov test to assess nor-
mality of data distribution. Baseline clinicopathologic
characteristics between the OT and RT groups were
compared by using the Fisher’s exact test for categorical
variables and the independent sample t test or Mann-
Whitney U test for continuous variables. After propen-
sity score matching, the two groups were compared in
terms of baseline clinicopathologic characteristics and
surgical outcomes by using the McNemar test for cat-
egorical variables and the paired t test for continuous
variables. All statistical tests were two-sided, and a
P value <0.05 was considered statistically significant.
Statistical analysis was performed using SPSS® version
19.0 (IBM Co., Armonk, NY, USA). The study protocol
was approved by our Institutional Review Board.
Results
Baseline characteristics of the study groups before cohort
matching
Table 1 shows the baseline clinicopathologic characteris-
tics of the two groups before propensity score matching.
The mean age was lower in the RT group than that in
the OT group (39.86 ± 10.29 years vs. 52.15 ± 12.06 years,
P < 0.001). The BMI was lower in the RT group (23.40
[range, 15.45–37.77] vs. 24.45 [range, 17.10–37.79], P =
0.001). The proportions of stage III disease and total thy-
roidectomy were significantly lower in the RT group
than that in the OT group (P < 0.001, P = 0.027).
Baseline characteristics of the study groups after cohort
matching
Table 2 shows the baseline clinicopathologic character-
istics of the two groups after propensity score match-
ing. After cohort matching, 109 pairs of patients were
selected in the two groups. The 10 covariates that could
affect the surgical outcomes were used to calculate the
propensity score, and significant differences in covari-
ates such as age, BMI, extent of surgery, and stage
which were observed before the matching were no lon-
ger present.
Comparison of surgical outcomes
Table 3 shows the comparison of surgical outcomes be-
tween the two groups. The operation time was longer in
the RT group (P < 0.001), and the total amount of hos-
pital cost was higher in the RT group than that in the
OT group (P < 0.001). There were no significant differ-
ences between the two groups in the length of hospital
stay (P = 0.293) and postoperative pain score (P = 0.669).
Postoperative complications showed no differences be-
tween the two groups (minor complications [P = 0.852],
major complications [P = 0.754]). The number of cases
that showed identification of the parathyroid gland with
permanent pathology (P = 1.000) and the number of para-
thyroid glands saved during the operation (P = 0.160) were
not different between the two groups.
Radioiodine ablation therapy was conducted in 61.5 %
of patients in the RT group (67/109 patients) and in
47.7 % of patients in the OT group (52/109 patients).
The mean TSH-stimulated Tg level was not different
between the two groups (P = 0.954).
There was no difference between the two groups in
the mean number of metastatic lymph nodes, but the
RT group showed less number of retrieved lymph nodes
than the OT group (3.50 ± 3.55 [range, 0–17] vs. 5.29 ±
5.25 [range, 0–29]).
Discussion
We conducted this study to analyze our initial experi-
ences of BABA robotic thyroidectomy for the last 5 years
and to compare the surgical outcomes between RT and
OT for assessing the feasibility of robotic thyroidectomy
for PTC.
In our study, baseline clinicopathologic characteristics
were different between the two groups. The RT group
showed a lower mean age, lower mean BMI, higher pro-
portion of lobectomy than total thyroidectomy, and
lower stage (UICC/AJCC seventh edition), although the
tumor size was not different. These differences may be
due to a greater desire to avoid a visible anterior neck
scar in younger patients, and RT was not recommended
in the patients with clinically suspected lymph node me-
tastases. Thus, the findings of this study were inevitably
influenced by several confounding factors including a
selection bias between the RT and OT groups. The
patient’s preferences and narrow indication for RT in
our hospital may be the major causes of selection bias.
We think that the economic burden of robotic surgery is
the main reason why we cannot conduct a randomized
study.
The propensity score analysis was used to reduce the
confounding factors [27]. Several clinical features and
surgical outcomes were compared between the paired
109 patients in both groups after propensity score
matching analysis.
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Table 2 Baseline characteristics of patients, after propensity score matching
Variables Open group Robot group P value
(n = 109) (n = 109)
Age, years (mean ± SD) 40.81 ± 10.84 41.78 ± 9.36 0.259
Sex, female (%) 91 (83.5) 94 (86.2) 0.700
BMI (median (range)) 23.73 (17.58–33.37) 24.53 (16.63–37.77) 0.984
Extent of surgery (total thyroidectomy [%]) 93 (85.1) 88 (80.7) 0.278
Lymph nodes dissection 0.940
None (%) 15 (13.8) 14 (12.8)
Unilateral (%) 72 (66.1) 75 (68.8)
Bilateral (%) 22 (20.2) 20 (18.3)
Tumor size (cm, median (range)) 0.7 (0.2–2.5) 0.7 (0.2–2.5) 0.331
Multiplicity (%) 25 (22.9) 28 (25.7) 0.760
Bilaterality (%) 20 (18.3) 21 (19.3) 1.000
Extrathyroidal extension (%) 36 (33.0) 38 (34.9) 0.888
Stage (I/III, %) 92 (89.0)/12 (11.0) 93 (85.3)/16 (14.7) 0.317
Table 1 Baseline characteristics of patients before propensity score matching
Variables Open group Robot group P value
n = 689 n = 126
Age, years (mean ± SD) 52.15 ± 12.06 39.86 ± 10.29 < 0.001
Gender 0.351
Male (%) 110 (16.0) 16 (12.7)
Female (%) 579 (84.0) 110 (87.3)
BMI (median (range)) 24.45 (17.10–37.79) 23.40 (15.45–37.77) 0.001
Extent of surgery 0.027
Total thyroidectomy (%) 583 (84.6) 99 (78.6)
Subtotal thyroidectomy (%) 1 (0.1) 2 (1.6)
Lobectomy (%) 105 (15.2) 25 (19.8)
Lymph nodes dissection 0.400
None (%) 67 (9.7) 21 (16.7)
Unilateral (%) 461 (66.9) 83 (65.9)
Bilateral (%) 161 (23.4) 22 (17.5)
No. of metastatic lymph nodes (mean ± SD (range)) 0.90 ± 2.07 (0–19) 0.70 ± 1.54 (0–9) 0.611
No. of retrieved lymph nodes (mean ± SD (range)) 5.12 ± 4.52 (0–35) 3.35 ± 3.48 (0–17) < 0.001
Tumor size (cm, median (range)) 0.76 (0.1–4.7) 0.74 (0.2–2.5) 0.389
Multiplicity (%) 201 (29.2) 31 (24.6) 0.334
Bilaterality (%) 157 (26.9, 157/584) 23 (22.8, 23/101) 0.294
Extrathyroidal extension (%) 281 (40.8) 45 (35.7) 0.323
Stage (%) < 0.001
I 405 (58.8) 109 (86.5)
II 6 (0.9) 0 (0)
III 278 (40.3) 17 (13.5)
IV 0 (0) 0 (0)
Cho et al. World Journal of Surgical Oncology  (2016) 14:181 Page 4 of 7
The RT group showed a significantly longer operating
time. The main contributing factors are the process of
creating the flap and robotic docking, which are required
for the robotic system operation, and most of the other
studies showed similar results [8–24]. But, the robotic
operative time is likely to decrease with accumulation of
experience and overcoming the learning curve [7].
As expected, the hospital cost in the RT group was
about three times higher than that in the OT group.
Although we cannot ignore the fact that robotic sur-
gery causes an increase in the total health cost, from a
personal point of view, this problem can be solved by
lowering the price via competing with other suppliers.
In addition, the problem of high cost may be naturally
resolved when robotic surgery is popularized like lap-
aroscopic surgery. Most importantly, it can be affordable
enough on considering additional excellent cosmetic ben-
efits [10, 11].
On the assessment of safety of RT, there was no sig-
nificant difference in complication rates between the two
groups. This may be an important result on considering
the advantage of robotic surgery like fine movement and
magnification view. Equivalence of complication rates is
enough to demonstrate the safety of RT, considering the
low incidence of serious complications after OT.
TSH-stimulated Tg level measured for assessing sur-
gical completeness in papillary thyroid carcinoma was
not different between the two groups. TSH-stimulated
Tg is one of the important clinical parameters that
reflect surgical completeness [30]. The study that par-
ticularly analyzed surgical completeness of RT showed a
similar result [12], and there is a study that showed su-
periority of surgical completeness of RT [13]. In this
study, while there was no difference in the TNM stage
between the two groups, the rates of RAI ablation ther-
apy was higher in the RT group (Table 3). This differ-
ence might have resulted from aggressive treatment
policy at our institution. We performed RAI ablation
therapy in accordance with the ATA guidelines [29] in
most cases, but selected patients with stage I disease
who received RAI ablation therapy, especially those
with angiolymphatic invasion, multifocal disease, nodal
disease, and aggressive histology.
There was no difference in the number of metastatic
lymph nodes between the two groups, but the number
of retrieved lymph nodes was lower in the RT group. To
date, there is no consensus about the prognostic impli-
cations of lymph node ratio in PTC. The recently pub-
lished seventh UICC/AJCC staging criteria of thyroid
carcinoma do not evaluate lymph node ratio [28]. But,
Table 3 Comparison of the surgical outcomes between two groups, after propensity score matching
Variables Open group Robot group P value
n = 109 n = 109
Operation time (min, mean ± SD (range)) 107.94 ± 30.84 (60–280) 290.57 ± 74.37 (160–715) < 0.001
Hospital stay (days, mean ± SD (range)) 3.40 ± 1.24 (2–11) 3.56 ± 0.83 (2–8) 0.293
Cost ($, mean ± SD) 2995 ± 695 7,632 ± 1,282 < 0.001
Pain score, operation day (mean ± SD (range)) 3.84 ± 1.11 (0–7) 3.76 ± 1.22 (0–7) 0.669
Pain score, postoperative 1 day (mean ± SD (range)) 2.36 ± 0.99 (0–5) 2.38 ± 1.06 (0–5) 0.952
Parathyroid gland in pathology 42 (38.5) 41 (37.6) 1.000
Identified number of parathyroid glands during surgery (mean ± SD (range)) 2.68 ± 0.88 (0–4) 2.54 ± 0.87 (1–4) 0.160
Minor complication (%) 37 (34) 43 (39) 0.852
Transient hypocalcemia 29 36
Transient hoarseness 6 7
Wound seroma 1 0
Wound infection 1 0
Major complication (%) 6 (5.5) 4 (3.7) 0.754
Bleeding 1 1
Chyle leakage 2 0
Permanent hoarseness 1 1
Permanent hypocalcemia 2 2
Radioiodine ablation (%) 52 (47.7) 67 (61.5) 0.033
Stimulated thyroglobulin (ng/mL, median (range)) 0.25 (0–66.7) 0.20 (0–6.8) 0.954
No. of metastatic lymph nodes (mean ± SD (range)) 1.26 ± 3.07 (0–19) 0.60 ± 1.26 (0–5) 0.133
No. of retrieved lymph nodes (mean ± SD (range)) 5.29 ± 5.25 (0–29) 3.50 ± 3.55 (0–17) 0.002
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the importance of the LN ratio in PTC has been re-
ported [31–35] and it is likely to have a greater onco-
logical significance in PTC, as in cases of other solid
organ cancers [36–38]. Although the follow-up period
was short (range, 22–68 months), there was no case of
recurrence in the RT group.
Although the absolute value of the retrieved lymph
nodes seemed to show a marginal difference, similar re-
sults were observed in other studies and meta-analysis
[14–16]. The limitation of central node dissection was
also reported with a trans-axillary approach [17, 18].
Despite the strong advantages of the robotic arm multi-
articulated joint system, directional rigidity of the scope
and restricted view of the lower part of the neck are
considered to be the most important causes of limitation
of central node dissection and it is a matter that needs
to be carefully considered as a limitation of RT.
However, several studies reported that the number of
retrieved lymph nodes in central node dissection is simi-
lar in both robotic and open thyroidectomies [19, 20],
and various methods are being attempted to overcome
the limitation of the field of view in the lower part of the
neck (e.g., make widening the camera view by applying
elastic bandage at the lower breast and change the oper-
ation table to reverse Trendelenburg position) [15]. The
most important part to ensure good visibility of the lower
part of the neck is secure sufficient space at the lower
neck region during the process of creating the flap.
In our experience, with the sense of incompatibility,
the great feature of the robot joint function was not fully
utilized at the beginning of robotic surgery. This could
simply indicate the learning curve, but familiarity of con-
ventional endoscopic or laparoscopic equipment can act
as additional difficulties for expert surgeons. And, the
result of this study with a lower number of retrieved
lymph node might have been influenced by 30~40 of
cases of the early period. It will be explained with further
analysis after the experience has accumulated.
Currently, BABA RT has not been accepted as a
standard surgical method for PTC, but results of recent
studies including a meta-analysis generally show favor-
able surgical outcomes of RT [21–23]. Accordingly,
recent interests are being focused on functional benefits
of RT. We analyzed postoperative pain with respect to
functional benefit, and there was no significant differ-
ence between the two groups. Results for cosmetic sat-
isfaction [10, 11], sensory change in the anterior neck
region [24], swallowing discomfort [25], and voice im-
pairments [26] were similar or better with RT compared
to OT as well as pain.
Conclusions
In conclusion, our observational study showed that BABA
RT is feasible in terms of surgical safety and surgical
completeness that are estimated by postoperative com-
plications and TSH-stimulated Tg, respectively, when
compared with OT after adjusting for the selection bias
by propensity score matching analysis. But, we could
not confirm the oncological safety of BABA RT because
it showed limitations in the central compartment LN
dissection. In order to establish a clear surgical indica-
tion for RT, more evidences are needed that can ensure
both surgical and oncological safety.
Abbreviations
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